Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Microneedling with topical silymarin versus diode laser and scalpel for gingival pigmentation

Official title: Clinical Evaluation of Microneedling Technique With Topical Application of Silymarin on Gingival Hyperpigmentation in Comparison With Diode Laser and Scalpel Methods. A Randomized Clinical Trial

Run by Fayoum University · NCT07410156 · Data updated 2026-11-12

We will test whether microneedling plus topical silymarin, diode laser, or scalpel works better to improve the appearance of gums in people with gingival hyperpigmentation.

More Gingival Pigmentation trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorFayoum University
Academic / other
Locations1 site (Al Fayyum)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedJuly 2027
Study endsDecember 2027
Registry record updatedFebruary 13, 2026
Trial IDNCT07410156 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with physiologic gingival hyperpigmentation who are non-smokers, free of systemic disease, not pregnant or lactating, and without allergy to silymarin.

Probably not a fit

People with medication- or disease-related pigmentation, smokers, pregnant or breastfeeding women, or those allergic to silymarin likely would not benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional comparison will treat selected gingival sites by one of three methods: scalpel de-epithelialization using a No. 15c blade, diode laser (serolaser) ablation, or repetitive microneedling with a Dr.Pen device followed by topical silymarin application. Clinical and aesthetic outcomes, healing, and any adverse effects will be recorded and compared across groups. Eligible non-smoking adults with physiologic gingival pigmentation and no systemic conditions or silymarin allergy will be enrolled after informed consent. All procedures and follow-up visits will be conducted at Fayoum University Faculty of Dentistry.

Why it matters

Potential benefit: If successful, this could offer a less invasive or better-tolerated option that improves gum color with comparable safety and faster healing.

How similar studies have gone: Scalpel and diode laser methods are established and have shown positive results for gingival depigmentation, while microneedling with topical silymarin is a novel approach with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients will be free from any systemic diseases according to criteria of Modified Cornell Medical Index
2. Patient with physiologic pigmentation
3. Non smoker
4. Patient agree to sign the written consent
5. Both genders

Exclusion Criteria:

1. Pregnant and lactating women
2. Systemic conditions affect melanin production
3. Medications induce pigmentation or enlargement
4. Those with known allergies to silymarin.

Where it's running

  • Fayoum University, Faculty of Dentistry, Department of Oral Medicine and Periodontology
    Al Fayyum, Egypt
    Recruiting

Study contacts

  • Principal investigator: Nayroz Mohammed Tarrad, Professor — Oral Medicine and Periodontology Faculty of Dentistry, Fayoum University
  • Study coordinator: Tarek Taha TTAAbdeltawab, Researcher
  • Email: tt1139@fayoum.edu.eg
  • Phone: +201100892663

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.